Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;28(3):253-272.
doi: 10.1016/j.fsc.2020.03.004. Epub 2020 May 6.

Subunit Approach to Facelifting and Facial Rejuvenation

Babak Azizzadeh  1 , Rebecca Fitzgerald  2 , Guy Massry  3 , Erin Smith  4
Affiliations
Review

Subunit Approach to Facelifting and Facial Rejuvenation

Babak Azizzadeh et al. Facial Plast Surg Clin North Am. 2020 Aug.

Abstract

Facial analysis techniques traditionally separate the upper, middle, and lower facial thirds as distinct entities without guidance in achieving aesthetic youthfulness. There is now an opportunity to develop better analytical tools and specific algorithms to help create an overall harmony to the face and restore a youthful appearance. Facial anatomic subunits have similar three-dimensional qualities based on underlying anatomic structures, craniofacial skeletal modeling, superficial and deep facial fat compartments, skin thickness, facial muscle activity, and curvature (flat, convex, concave). This article discusses using the relationships of the facial anatomic subunits to obtain more consistent and natural facial rejuvenation outcomes.

Keywords: FASA; Facelift; Facial aesthetic surgery; Facial rejuvenation; Rhytidectomy.

PubMed Disclaimer

Conflict of interest statement

Disclosure Drs B. Azizzadeh and G. Massry have no relevant conflict of interest with this article but do receive royalties from Wiley, Thieme, Elsevier, Springer, and Quality Medical Publishing. Dr R. Fitzgerald does training and research with Allergan, training with Galderma, and is on the advisory board for Allergan and Evolus. Dr E. Smith has no financial disclosures or conflicts of interest. No funding was received for this article.